Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
IRWD
— Ironwood Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 6, 2026
REVENUE
$113.0M
+6.1%
NET MARGIN
45.4%
+7.1 PTS
EPS
$0.31
+24.0%
FREE CASH FLOW
$58.3M
+1038.0%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →